Pureheart Capital Pte Ltd.

SINGAPORE, null · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$104.9M2026 Q3+ $10.4M options (notional, not included)
Positions4
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Pureheart Capital Pte Ltd. reported 4 positions worth $104.9M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: BF-B (37.2%).

4 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 BF-BBrown Forman$42.8M37.16%1,634,252——+15.4%
▸ 2 TSLATesla$36.2M31.41%102,000——+7.1%
▸ 3 DEODiageo$25.8M22.43%301,900——+17.7%
▸ 4 QQQPutInvesco QQQ Tr$10.4M notional8.99%14,000———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Pureheart Capital Pte Ltd. hold as of Q3 2026?

Pureheart Capital Pte Ltd. reported 4 positions worth $104.9M in its Q3 2026 13F filing. Largest positions: BF-B (37.2%), TSLA (31.4%), DEO (22.4%) and QQQ (9.0%).

What did Pureheart Capital Pte Ltd. buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Pureheart Capital Pte Ltd. sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.